| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.631 | 0.004 | 0.857 | Non-steroidal antiinflammatory agent | 0.857 0.003 CID_154699610 0.624 0.004 CID_154585067 0.582 0.005 CID_9904747 | CID_154699610 | |
| 0.629 | 0.003 | 0.629 | Interleukin 8 antagonist | 0.159 0.029 CID_154699610 0.42 0.004 CID_154585067 0.42 0.004 CID_9904747 | ||
| 0.634 | 0.044 | 0.8 | Antiinflammatory | 0.8 0.015 CID_154699610 0.676 0.035 CID_154585067 0.674 0.036 CID_9904747 | CID_154699610 | |
| 0.528 | 0.042 | 0.552 | Analgesic | 0.297 0.144 CID_154699610 0.504 0.048 CID_154585067 0.552 0.036 CID_9904747 | CID_9904747 | |
| 0.403 | 0.007 | 0.403 | Cyclooxygenase inhibitor | 0.32 0.015 CID_154699610 0.384 0.008 CID_154585067 0.384 0.008 CID_9904747 | ||
| 0.382 | 0.008 | 0.382 | Cyclooxygenase 1 inhibitor | 0.281 0.017 CID_154699610 0.364 0.009 CID_154585067 0.382 0.008 CID_9904747 | ||
| 0.428 | 0.076 | 0.64 | Cyclophilin D inhibitor | 0.64 0.021 CID_154699610 0.518 0.045 CID_154585067 0.47 0.06 CID_9904747 | CID_154699610 | |
| 0.312 | 0.004 | 0.312 | Prostaglandin-E synthase inhibitor | 0.28 0.004 CID_154585067 0.211 0.005 CID_9904747 | ||
| 0.319 | 0.011 | 0.319 | Cyclooxygenase 2 inhibitor | 0.244 0.021 CID_154699610 0.307 0.013 CID_154585067 0.302 0.013 CID_9904747 | ||
| 0.311 | 0.005 | 0.582 | Cyclooxygenase 3 inhibitor | 0.582 0.002 CID_154699610 0.307 0.006 CID_154585067 0.267 0.008 CID_9904747 | CID_154699610 | |
| 0.304 | 0.005 | 0.337 | Prostaglandin antagonist | 0.337 0.005 CID_154585067 0.211 0.006 CID_9904747 | CID_154585067 | |
| 0.287 | 0.005 | 0.287 | Potassium channel (Ca-activated) activator | 0.089 0.065 CID_154699610 0.212 0.012 CID_154585067 0.24 0.009 CID_9904747 | ||
| 0.283 | 0.008 | 0.321 | ATPase inhibitor | 0.321 0.005 CID_154699610 0.205 0.033 CID_154585067 0.292 0.007 CID_9904747 | CID_154699610 | |
| 0.383 | 0.116 | 0.383 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.326 | 0.059 | 0.423 | Lipoxygenase inhibitor | 0.338 0.055 CID_154585067 0.423 0.032 CID_9904747 | CID_9904747 | |
| 0.299 | 0.033 | 0.299 | Anesthetic general | 0.253 0.049 CID_154699610 0.25 0.05 CID_154585067 0.234 0.057 CID_9904747 | ||
| 0.321 | 0.06 | 0.442 | Interleukin 2 agonist | 0.442 0.017 CID_154699610 0.39 0.03 CID_154585067 0.315 0.064 CID_9904747 | CID_154699610 | |
| 0.295 | 0.037 | 0.295 | Gastrin inhibitor | 0.243 0.088 CID_154585067 0.22 0.119 CID_9904747 | ||
| 0.25 | 0.013 | 0.25 | Ferrochelatase inhibitor | 0.113 0.059 CID_154585067 0.121 0.053 CID_9904747 | ||
| 0.31 | 0.089 | 0.31 | Thyroid hormone antagonist | 0.294 0.096 CID_9904747 | ||
| 0.275 | 0.054 | 0.275 | Interleukin antagonist | 0.26 0.058 CID_154585067 0.264 0.057 CID_9904747 | ||
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.155 0.082 CID_154699610 0.214 0.021 CID_154585067 0.225 0.014 CID_9904747 | ||
| 0.29 | 0.093 | 0.29 | Thyroid hormone beta antagonist | 0.265 0.109 CID_9904747 | ||
| 0.302 | 0.108 | 0.353 | Toll-Like receptor 7 agonist | 0.353 0.08 CID_154585067 0.29 0.117 CID_9904747 | CID_154585067 | |
| 0.214 | 0.029 | 0.231 | Insulin secretagoues | 0.231 0.024 CID_154699610 0.206 0.033 CID_154585067 0.21 0.031 CID_9904747 | CID_154699610 | |
| 0.297 | 0.113 | 0.355 | Toll-Like receptor agonist | 0.355 0.079 CID_154585067 0.282 0.122 CID_9904747 | CID_154585067 | |
| 0.24 | 0.057 | 0.24 | ErbB-1 antagonist | 0.226 0.066 CID_154585067 0.212 0.077 CID_9904747 | ||
| 0.321 | 0.142 | 0.321 | 5 Hydroxytryptamine release inhibitor | 0.276 0.193 CID_154699610 0.278 0.191 CID_9904747 | ||
| 0.284 | 0.108 | 0.284 | Calcium channel activator | 0.264 0.13 CID_154585067 0.217 0.189 CID_9904747 | ||
| 0.171 | 0.005 | 0.171 | Sphingosine 1-phosphate receptor 4 agonist | 0.164 0.006 CID_154585067 0.135 0.012 CID_9904747 | ||
| 0.274 | 0.109 | 0.482 | Cholesterol antagonist | 0.482 0.036 CID_154699610 0.364 0.059 CID_154585067 0.234 0.137 CID_9904747 | CID_154699610 | |
| 0.176 | 0.016 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.163 0.024 CID_154585067 0.144 0.039 CID_9904747 | ||
| 0.205 | 0.045 | 0.205 | Succinate dehydrogenase inhibitor | 0.184 0.063 CID_154585067 0.184 0.063 CID_9904747 | ||
| 0.242 | 0.088 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.236 0.095 CID_154585067 0.185 0.184 CID_9904747 | ||
| 0.216 | 0.065 | 0.237 | Nitric-oxide synthase stimulant | 0.203 0.084 CID_154699610 0.237 0.042 CID_154585067 0.206 0.079 CID_9904747 | CID_154585067 | |
| 0.154 | 0.004 | 0.154 | Dihydroorotase inhibitor | 0.065 0.014 CID_154585067 0.076 0.009 CID_9904747 | ||
| 0.176 | 0.028 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.072 CID_154585067 0.17 0.034 CID_9904747 | ||
| 0.149 | 0.004 | 0.149 | Prostaglandin D2 antagonist | 0.133 0.004 CID_154585067 0.082 0.005 CID_9904747 | ||
| 0.187 | 0.046 | 0.307 | Interferon gamma antagonist | 0.307 0.019 CID_154699610 0.158 0.069 CID_154585067 0.212 0.037 CID_9904747 | CID_154699610 | |
| 0.148 | 0.007 | 0.221 | Phosphorylase inhibitor | 0.221 0.004 CID_154699610 0.218 0.005 CID_154585067 0.092 0.014 CID_9904747 | CID_154699610 | |
| 0.166 | 0.03 | 0.166 | Interleukin 1b antagonist | 0.161 0.033 CID_154585067 0.133 0.053 CID_9904747 | ||
| 0.154 | 0.019 | 0.154 | Potassium channel activator | 0.094 0.054 CID_154585067 0.102 0.045 CID_9904747 | ||
| 0.133 | 0.006 | 0.133 | Dihydroorotate dehydrogenase inhibitor | 0.104 0.01 CID_154585067 0.095 0.013 CID_9904747 | ||
| 0.208 | 0.089 | 0.232 | Hypolipemic | 0.222 0.081 CID_154699610 0.232 0.076 CID_154585067 0.222 0.081 CID_9904747 | CID_154585067 | |
| 0.238 | 0.119 | 0.256 | Nootropic | 0.256 0.103 CID_154585067 | CID_154585067 | |
| 0.166 | 0.048 | 0.166 | Interleukin 1 antagonist | 0.163 0.05 CID_154585067 0.119 0.09 CID_9904747 | ||
| 0.165 | 0.048 | 0.168 | MAP kinase 3 inhibitor | 0.168 0.045 CID_154585067 0.134 0.097 CID_9904747 | CID_154585067 | |
| 0.129 | 0.014 | 0.137 | Bile acid receptor antagonist | 0.117 0.022 CID_154585067 0.137 0.01 CID_9904747 | CID_9904747 | |
| 0.142 | 0.029 | 0.172 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.131 0.033 CID_154699610 0.172 0.021 CID_154585067 0.1 0.054 CID_9904747 | CID_154585067 | |
| 0.133 | 0.025 | 0.157 | MAP kinase kinase 1 inhibitor | 0.117 0.038 CID_154585067 0.157 0.014 CID_9904747 | CID_9904747 | |
| 0.113 | 0.008 | 0.125 | Thromboxane antagonist | 0.125 0.006 CID_154585067 0.081 0.019 CID_9904747 | CID_154585067 | |
| 0.145 | 0.048 | 0.145 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.07 CID_154585067 0.141 0.053 CID_9904747 | ||
| 0.139 | 0.043 | 0.157 | CC chemokine 6 receptor antagonist | 0.157 0.015 CID_154699610 0.129 0.076 CID_154585067 0.136 0.05 CID_9904747 | CID_154699610 | |
| 0.123 | 0.028 | 0.123 | ABCA1 expression enhancer | 0.111 0.038 CID_154585067 0.113 0.036 CID_9904747 | ||
| 0.101 | 0.007 | 0.109 | Thromboxane A2 antagonist | 0.109 0.006 CID_154585067 0.075 0.018 CID_9904747 | CID_154585067 | |
| 0.207 | 0.114 | 0.28 | Interleukin agonist | 0.28 0.059 CID_154699610 0.274 0.063 CID_154585067 | CID_154699610 | |
| 0.099 | 0.007 | 0.099 | Diacylglycerol O-acyltransferase inhibitor | 0.083 0.013 CID_154585067 0.057 0.028 CID_9904747 | ||
| 0.128 | 0.037 | 0.139 | DOPA decarboxylase inhibitor | 0.121 0.044 CID_154585067 0.139 0.028 CID_9904747 | CID_9904747 | |
| 0.183 | 0.093 | 0.183 | MAP kinase kinase 2 inhibitor | 0.152 0.12 CID_154585067 0.145 0.126 CID_9904747 | ||
| 0.185 | 0.098 | 0.185 | EphB2 antagonist | 0.179 0.104 CID_9904747 | ||
| 0.163 | 0.077 | 0.163 | Catenin beta inhibitor | 0.154 0.096 CID_9904747 | ||
| 0.123 | 0.038 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | 0.193 0.013 CID_154585067 0.084 0.073 CID_9904747 | CID_154585067 | |
| 0.231 | 0.149 | 0.281 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 CID_154585067 0.281 0.097 CID_9904747 | CID_9904747 | |
| 0.103 | 0.022 | 0.103 | Potassium channel large-conductance Ca-activated activator | 0.086 0.031 CID_154585067 0.096 0.026 CID_9904747 | ||
| 0.086 | 0.007 | 0.086 | CXC chemokine 1 receptor antagonist | 0.082 0.008 CID_154585067 0.082 0.008 CID_9904747 | ||
| 0.153 | 0.076 | 0.247 | Hexokinase inhibitor | 0.247 0.018 CID_154699610 0.157 0.071 CID_154585067 | CID_154699610 | |
| 0.121 | 0.044 | 0.121 | Interleukin 2 antagonist | 0.103 0.082 CID_154585067 | ||
| 0.149 | 0.075 | 0.149 | Phospholipase A2 inhibitor | 0.149 0.075 CID_154585067 0.138 0.088 CID_9904747 | ||
| 0.112 | 0.043 | 0.112 | Electrolyte absorption antagonist | 0.089 0.075 CID_9904747 | ||
| 0.112 | 0.044 | 0.129 | DNA directed RNA polymerase inhibitor | 0.096 0.061 CID_154585067 0.129 0.032 CID_9904747 | CID_9904747 | |
| 0.108 | 0.044 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.12 0.031 CID_154585067 | CID_154585067 | |
| 0.104 | 0.044 | 0.137 | Triose-phosphate isomerase inhibitor | 0.137 0.024 CID_154699610 0.122 0.031 CID_154585067 0.08 0.077 CID_9904747 | CID_154699610 | |
| 0.081 | 0.022 | 0.087 | Prostaglandin F2 alpha antagonist | 0.07 0.032 CID_154585067 0.087 0.017 CID_9904747 | CID_9904747 | |
| 0.085 | 0.026 | 0.085 | NMDA receptor agonist | 0.057 0.052 CID_154585067 0.058 0.051 CID_9904747 | ||
| 0.084 | 0.026 | 0.084 | NMDA receptor glycine site agonist | |||
| 0.068 | 0.012 | 0.068 | Carnitine palmitoyltransferase 1B inhibitor | 0.058 0.019 CID_154585067 0.055 0.022 CID_9904747 | ||
| 0.094 | 0.038 | 0.094 | D-Ala-D-Ala ligase inhibitor | 0.087 0.05 CID_154585067 0.09 0.044 CID_9904747 | ||
| 0.104 | 0.048 | 0.104 | Potassium channel (Voltage-sensitive) activator | |||
| 0.125 | 0.069 | 0.186 | MAP kinase kinase inhibitor | 0.112 0.082 CID_154585067 0.186 0.033 CID_9904747 | CID_9904747 | |
| 0.143 | 0.088 | 0.143 | Src kinase inhibitor | 0.121 0.107 CID_154585067 0.13 0.099 CID_9904747 | ||
| 0.087 | 0.033 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.086 0.035 CID_154585067 0.073 0.062 CID_9904747 | ||
| 0.077 | 0.024 | 0.083 | MDM2 inhibitor | 0.083 0.016 CID_154585067 | CID_154585067 | |
| 0.146 | 0.095 | 0.146 | Interleukin 6 antagonist | 0.143 0.101 CID_154699610 | ||
| 0.063 | 0.015 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 CID_154585067 0.051 0.024 CID_9904747 | ||
| 0.097 | 0.049 | 0.106 | NMDA receptor antagonist | 0.106 0.043 CID_9904747 | CID_9904747 | |
| 0.128 | 0.08 | 0.128 | Lck kinase inhibitor | |||
| 0.066 | 0.019 | 0.069 | Leukotriene C antagonist | 0.069 0.015 CID_154585067 0.062 0.026 CID_9904747 | CID_154585067 | |
| 0.085 | 0.038 | 0.087 | Peroxisome proliferator-activated receptor gamma agonist | 0.077 0.043 CID_154585067 0.087 0.036 CID_9904747 | CID_9904747 | |
| 0.055 | 0.008 | 0.055 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.046 0.01 CID_154585067 0.031 0.019 CID_9904747 | ||
| 0.066 | 0.02 | 0.066 | DNA helicase inhibitor | 0.054 0.038 CID_154585067 0.061 0.027 CID_9904747 | ||
| 0.058 | 0.014 | 0.08 | Liver X receptor alpha agonist | 0.08 0.007 CID_154585067 0.056 0.015 CID_9904747 | CID_154585067 | |
| 0.062 | 0.02 | 0.108 | Heparanase inhibitor | 0.108 0.004 CID_154699610 0.069 0.012 CID_154585067 0.055 0.032 CID_9904747 | CID_154699610 | |
| 0.063 | 0.022 | 0.063 | Sphingosine 1-phosphate receptor 5 agonist | 0.062 0.023 CID_154585067 0.059 0.027 CID_9904747 | ||
| 0.047 | 0.006 | 0.047 | NMDA receptor glycine site antagonist | 0.022 0.02 CID_154585067 0.031 0.012 CID_9904747 | ||
| 0.16 | 0.121 | 0.204 | Growth factor agonist | 0.204 0.059 CID_154585067 | CID_154585067 | |
| 0.127 | 0.088 | 0.16 | Farnesoid X receptor antagonist | 0.16 0.042 CID_9904747 | CID_9904747 | |
| 0.076 | 0.039 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.059 CID_154585067 0.071 0.051 CID_9904747 | ||
| 0.042 | 0.007 | 0.042 | CXC chemokine 2 receptor antagonist | 0.031 0.013 CID_154585067 0.037 0.009 CID_9904747 | ||
| 0.075 | 0.041 | 0.083 | Elastase 1 inhibitor | 0.083 0.032 CID_154585067 0.068 0.05 CID_9904747 | CID_154585067 | |
| 0.125 | 0.093 | 0.138 | Mannose-6-phosphate isomerase inhibitor | 0.138 0.076 CID_154699610 | CID_154699610 | |
| 0.067 | 0.035 | 0.082 | Prostaglandin EP2 antagonist | 0.082 0.026 CID_154585067 0.061 0.04 CID_9904747 | CID_154585067 | |
| 0.042 | 0.013 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | 0.039 0.016 CID_154585067 0.045 0.012 CID_9904747 | CID_9904747 | |
| 0.039 | 0.009 | 0.042 | Elastase 2B inhibitor | 0.029 0.026 CID_154699610 0.042 0.007 CID_154585067 0.035 0.014 CID_9904747 | CID_154585067 | |
| 0.039 | 0.009 | 0.042 | Elastase 3A inhibitor | 0.029 0.026 CID_154699610 0.042 0.007 CID_154585067 0.035 0.014 CID_9904747 | CID_154585067 | |
| 0.039 | 0.009 | 0.042 | Elastase 3B inhibitor | 0.029 0.026 CID_154699610 0.042 0.007 CID_154585067 0.035 0.014 CID_9904747 | CID_154585067 | |
| 0.107 | 0.078 | 0.107 | Cholesterol synthesis inhibitor | |||
| 0.052 | 0.023 | 0.052 | NMDA receptor subunit 3B antagonist | 0.046 0.028 CID_9904747 | ||
| 0.045 | 0.017 | 0.045 | Potassium channel Kv1.1 blocker | |||
| 0.06 | 0.032 | 0.075 | Aldose reductase inhibitor | 0.055 0.035 CID_154585067 0.075 0.025 CID_9904747 | CID_9904747 | |
| 0.037 | 0.011 | 0.037 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.094 | 0.068 | 0.136 | 5-Lipoxygenase inhibitor | 0.098 0.066 CID_154585067 0.136 0.043 CID_9904747 | CID_9904747 | |
| 0.076 | 0.05 | 0.076 | MAP kinase 14 inhibitor | |||
| 0.068 | 0.044 | 0.068 | Potassium channel (ATP-sensitive) blocker | |||
| 0.1 | 0.076 | 0.1 | EphA2 antagonist | 0.094 0.082 CID_154585067 | ||
| 0.045 | 0.022 | 0.045 | NMDA receptor subunit 3A antagonist | 0.038 0.027 CID_9904747 | ||
| 0.074 | 0.051 | 0.074 | CDC25A inhibitor | 0.074 0.051 CID_154585067 0.072 0.054 CID_9904747 | ||
| 0.042 | 0.02 | 0.044 | Leukotriene C4 antagonist | 0.044 0.017 CID_154585067 0.038 0.029 CID_9904747 | CID_154585067 | |
| 0.041 | 0.019 | 0.041 | p53 inhibitor | 0.036 0.024 CID_154585067 | ||
| 0.038 | 0.018 | 0.038 | Free fatty acid receptor 1 antagonist | 0.033 0.024 CID_154585067 | ||
| 0.037 | 0.018 | 0.06 | Liver X receptor beta agonist | 0.06 0.008 CID_154585067 0.039 0.016 CID_9904747 | CID_154585067 | |
| 0.093 | 0.075 | 0.093 | Urease inhibitor | 0.092 0.077 CID_9904747 | ||
| 0.035 | 0.018 | 0.043 | ATP citrate lysase inhibitor | 0.043 0.011 CID_9904747 | CID_9904747 | |
| 0.034 | 0.018 | 0.05 | Prostaglandin agonist | 0.05 0.01 CID_154585067 0.033 0.018 CID_9904747 | CID_154585067 | |
| 0.028 | 0.012 | 0.044 | Prostaglandin E2 agonist | 0.044 0.006 CID_154585067 0.027 0.013 CID_9904747 | CID_154585067 | |
| 0.062 | 0.047 | 0.068 | CDC25B inhibitor | 0.068 0.04 CID_154699610 0.068 0.04 CID_154585067 0.06 0.051 CID_9904747 | CID_154585067 | |
| 0.028 | 0.013 | 0.042 | Prostaglandin EP2 agonist | 0.042 0.008 CID_154585067 0.025 0.015 CID_9904747 | CID_154585067 | |
| 0.101 | 0.087 | 0.189 | Cell adhesion inhibitor | 0.189 0.028 CID_154699610 0.101 0.087 CID_154585067 | CID_154699610 | |
| 0.041 | 0.028 | 0.041 | Kainate receptor antagonist | |||
| 0.094 | 0.082 | 0.098 | Protein kinase (CK2) alpha inhibitor | 0.098 0.078 CID_9904747 | CID_9904747 | |
| 0.035 | 0.022 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 CID_154585067 | ||
| 0.037 | 0.025 | 0.037 | Integrin alpha2 antagonist | 0.036 0.027 CID_154585067 | ||
| 0.055 | 0.044 | 0.065 | Pregnane X receptor antagonist | 0.065 0.022 CID_9904747 | CID_9904747 | |
| 0.054 | 0.043 | 0.087 | Adenine nucleotide translocase inhibitor | 0.087 0.007 CID_154699610 0.061 0.026 CID_9904747 | CID_154699610 | |
| 0.104 | 0.093 | 0.262 | Amylase inhibitor | 0.262 0.025 CID_154699610 0.145 0.067 CID_154585067 0.102 0.094 CID_9904747 | CID_154699610 | |
| 0.058 | 0.048 | 0.058 | NMDA 2C receptor antagonist | |||
| 0.03 | 0.019 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 CID_154585067 | CID_154585067 | |
| 0.072 | 0.062 | 0.072 | GABA B receptor agonist | |||
| 0.072 | 0.062 | 0.09 | Keratolytic | 0.083 0.045 CID_154585067 0.09 0.037 CID_9904747 | CID_9904747 | |
| 0.035 | 0.026 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.19 | 0.181 | 0.329 | Angiogenesis inhibitor | 0.329 0.08 CID_154699610 0.22 0.148 CID_9904747 | CID_154699610 | |
| 0.018 | 0.009 | 0.023 | Thyroid hormone alpha agonist | 0.016 0.012 CID_154585067 0.023 0.005 CID_9904747 | CID_9904747 | |
| 0.087 | 0.079 | 0.092 | Interleukin 12 antagonist | 0.087 0.08 CID_154699610 0.091 0.07 CID_154585067 0.092 0.068 CID_9904747 | CID_9904747 | |
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | 0.017 0.012 CID_154585067 | ||
| 0.056 | 0.05 | 0.066 | Purinergic P2X1 antagonist | 0.06 0.044 CID_154585067 0.066 0.036 CID_9904747 | CID_9904747 | |
| 0.04 | 0.034 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 CID_9904747 | CID_9904747 | |
| 0.031 | 0.026 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.028 | 0.022 | 0.028 | AMPA 3 receptor antagonist | |||
| 0.104 | 0.099 | 0.104 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.036 | 0.031 | 0.036 | Glutamate (mGluR8) agonist | 0.035 0.032 CID_154585067 0.036 0.032 CID_9904747 | ||
| 0.047 | 0.043 | 0.047 | Potassium channel (Inward rectifier) activator | |||
| 0.027 | 0.023 | 0.039 | Liver X receptor alpha antagonist | 0.039 0.01 CID_154585067 0.027 0.024 CID_9904747 | CID_154585067 | |
| 0.024 | 0.021 | 0.047 | Thyroid hormone agonist | 0.047 0.005 CID_9904747 | CID_9904747 | |
| 0.045 | 0.041 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.015 | 0.012 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.042 | 0.04 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.044 | 0.042 | 0.074 | Prostaglandin E2 antagonist | 0.074 0.022 CID_154585067 | CID_154585067 | |
| 0.024 | 0.023 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.022 CID_154585067 | CID_154585067 | |
| 0.031 | 0.03 | 0.031 | Glutamate (mGluR4) agonist | |||
| 0.044 | 0.043 | 0.044 | NMDA 2A receptor antagonist | |||
| 0.023 | 0.022 | 0.03 | Prostaglandin EP4 antagonist | 0.03 0.015 CID_154585067 | CID_154585067 | |
| 0.026 | 0.025 | 0.031 | Prostaglandin EP3 antagonist | 0.031 0.021 CID_154585067 | CID_154585067 | |
| 0.013 | 0.015 | 0.019 | Thyroid hormone alpha antagonist | 0.019 0.008 CID_9904747 | CID_9904747 | |
| 0.026 | 0.029 | 0.038 | Liver X receptor antagonist | 0.038 0.015 CID_154585067 | CID_154585067 | |
| 0.037 | 0.042 | 0.047 | Liver X receptor agonist | 0.047 0.025 CID_154585067 | CID_154585067 | |
| 0.031 | 0.036 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_154585067 | CID_154585067 | |
| 0.059 | 0.064 | 0.067 | NMDA 2 receptor antagonist | 0.067 0.054 CID_9904747 | CID_9904747 | |
| 0.087 | 0.094 | 0.103 | Cystathionine beta-synthase inhibitor | 0.103 0.073 CID_9904747 | CID_9904747 | |
| 0.059 | 0.066 | 0.078 | Catalase inhibitor | 0.078 0.049 CID_154585067 | CID_154585067 | |
| 0.005 | 0.013 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 CID_9904747 | CID_9904747 | |
| 0.049 | 0.057 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.047 CID_154585067 | CID_154585067 | |
| 0.076 | 0.084 | 0.08 | T cell inhibitor | 0.08 0.066 CID_154699610 | CID_154699610 | |
| 0.247 | 0.257 | 0.338 | Caspase 9 stimulant | 0.338 0.155 CID_154699610 0.309 0.184 CID_154585067 | CID_154699610 | |
| 0.012 | 0.022 | 0.016 | Free fatty acid receptor 1 agonist | 0.016 0.014 CID_154585067 | CID_154585067 | |
| 0.067 | 0.078 | 0.114 | Cell adhesion molecule inhibitor | 0.114 0.027 CID_154699610 | CID_154699610 | |
| 0.052 | 0.064 | 0.07 | Leukotriene antagonist | 0.07 0.04 CID_154585067 | CID_154585067 | |
| 0.084 | 0.097 | 0.114 | Carbonic anhydrase XV inhibitor | 0.114 0.052 CID_154585067 0.091 0.082 CID_9904747 | CID_154585067 | |
| 0.052 | 0.068 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 CID_154585067 | CID_154585067 | |
| 0.013 | 0.031 | 0.017 | Complement factor D inhibitor | 0.017 0.016 CID_154585067 | CID_154585067 | |
| 0.076 | 0.094 | 0.087 | Creatine kinase inhibitor | 0.087 0.077 CID_9904747 | CID_9904747 | |
| 0.056 | 0.078 | 0.069 | Glutamate decarboxylase inhibitor | 0.069 0.057 CID_9904747 | CID_9904747 | |
| 0.138 | 0.163 | 0.241 | Antiamyloidogenic | 0.241 0.075 CID_154699610 0.198 0.101 CID_9904747 | CID_154699610 | |
| 0.039 | 0.064 | 0.088 | Factor IXa inhibitor | 0.088 0.013 CID_154699610 | CID_154699610 | |
| 0.189 | 0.216 | 0.213 | Histamine release inhibitor | 0.213 0.187 CID_154699610 | CID_154699610 | |
| 0.097 | 0.124 | 0.133 | Interleukin 4 antagonist | 0.131 0.07 CID_154699610 0.133 0.068 CID_9904747 | CID_9904747 | |
| 0.051 | 0.078 | 0.065 | Carbonic anhydrase VA inhibitor | 0.065 0.052 CID_154585067 | CID_154585067 | |
| 0.161 | 0.193 | 0.188 | 12-Lipoxygenase inhibitor | 0.188 0.165 CID_9904747 | CID_9904747 | |
| 0.048 | 0.084 | 0.125 | Histidine decarboxylase inhibitor | 0.125 0.024 CID_154585067 0.062 0.06 CID_9904747 | CID_154585067 | |
| 0.123 | 0.162 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.112 CID_154699610 | CID_154699610 | |
| 0.079 | 0.119 | 0.172 | Toll-Like receptor 4 antagonist | 0.172 0.012 CID_154699610 0.094 0.08 CID_154585067 | CID_154699610 | |
| 0.172 | 0.216 | 0.383 | Antithrombotic | 0.383 0.054 CID_154699610 0.226 0.148 CID_154585067 | CID_154699610 | |
| 0.041 | 0.089 | 0.061 | Carbonic anhydrase V inhibitor | 0.061 0.053 CID_154585067 | CID_154585067 | |
| 0.076 | 0.124 | 0.261 | Beta glucuronidase inhibitor | 0.261 0.008 CID_154699610 | CID_154699610 | |
| 0.078 | 0.127 | 0.154 | Multidrug resistance-associated protein 1 inhibitor | 0.154 0.024 CID_154699610 | CID_154699610 | |
| 0.075 | 0.129 | 0.109 | M18 aspartyl aminopeptidase inhibitor | 0.109 0.081 CID_9904747 | CID_9904747 | |
| 0.079 | 0.14 | 0.11 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.089 CID_154585067 | CID_154585067 | |
| 0.053 | 0.118 | 0.075 | Carbonic anhydrase VI inhibitor | 0.075 0.064 CID_154585067 | CID_154585067 | |
| 0.07 | 0.137 | 0.092 | Glutamate release inhibitor | 0.092 0.058 CID_154585067 | CID_154585067 | |
| 0.16 | 0.227 | 0.19 | Tyrosine 3 hydroxylase inhibitor | 0.19 0.155 CID_9904747 | CID_9904747 | |
| 0.06 | 0.131 | 0.084 | Ephrin antagonist | 0.084 0.079 CID_154585067 | CID_154585067 | |
| 0.058 | 0.13 | 0.085 | Alcohol dehydrogenase inhibitor | 0.085 0.071 CID_9904747 | CID_9904747 | |
| 0.049 | 0.121 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.036 CID_154585067 | CID_154585067 | |
| 0.099 | 0.173 | 0.199 | Hemostatic | 0.199 0.033 CID_154699610 0.119 0.117 CID_154585067 | CID_154699610 | |
| 0.151 | 0.226 | 0.55 | Transcription factor NF kappa B inhibitor | 0.55 0.038 CID_154699610 | CID_154699610 | |
| 0.049 | 0.125 | 0.087 | Adrenaline agonist | 0.087 0.049 CID_154585067 | CID_154585067 | |
| 0.078 | 0.155 | 0.104 | Toll-Like receptor 2 antagonist | 0.104 0.098 CID_154585067 | CID_154585067 | |
| 0.033 | 0.114 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.038 CID_154585067 | CID_154585067 | |
| 0.047 | 0.131 | 0.073 | Macrophage migration inhibitory factor inhibitor | 0.073 0.061 CID_9904747 | CID_9904747 | |
| 0.115 | 0.202 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 CID_154585067 | CID_154585067 | |
| 0.06 | 0.147 | 0.118 | Transcription factor NF kappa B stimulant | 0.118 0.026 CID_154699610 0.087 0.056 CID_154585067 | CID_154699610 | |
| 0.066 | 0.155 | 0.143 | AMP-activated protein kinase stimulant | 0.143 0.033 CID_154699610 0.09 0.086 CID_9904747 | CID_154699610 | |
| 0.058 | 0.151 | 0.107 | NADH dehydrogenase inhibitor | 0.107 0.037 CID_154699610 | CID_154699610 | |
| 0.155 | 0.248 | 0.448 | Immunosuppressant | 0.448 0.047 CID_154699610 | CID_154699610 | |
| 0.032 | 0.131 | 0.06 | Leukotriene synthesis inhibitor | 0.06 0.055 CID_154585067 | CID_154585067 | |
| 0.061 | 0.174 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.071 CID_9904747 | CID_9904747 | |
| 0.12 | 0.235 | 0.368 | Hypoglycemic | 0.368 0.034 CID_154699610 0.172 0.144 CID_154585067 0.179 0.136 CID_9904747 | CID_154699610 | |
| 0.098 | 0.224 | 0.184 | Platelet antagonist | 0.184 0.114 CID_154699610 | CID_154699610 | |
| 0.023 | 0.154 | 0.275 | Selectin antagonist | 0.275 0.007 CID_154699610 | CID_154699610 | |
| 0.084 | 0.216 | 0.198 | NOS3 expression enhancer | 0.198 0.042 CID_154699610 | CID_154699610 | |
| 0.008 | 0.144 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_154699610 | CID_154699610 | |
| 0.009 | 0.159 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CID_154699610 | CID_154699610 | |
| 0.087 | 0.248 | 0.408 | Immunostimulant | 0.408 0.047 CID_154699610 | CID_154699610 | |
| 0.085 | 0.272 | 0.365 | Tumour necrosis factor alpha release inhibitor | 0.365 0.034 CID_154699610 | CID_154699610 | |
| 0.027 | 0.222 | 0.111 | Monophenol monooxygenase inhibitor | 0.111 0.068 CID_154699610 | CID_154699610 | |
| 0.015 | 0.226 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 CID_154699610 | CID_154699610 | |
| 0.038 | 0.25 | 0.119 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 CID_154699610 | CID_154699610 | |
| 0.019 | 0.234 | 0.058 | Nitric oxide donor | 0.058 0.052 CID_154699610 | CID_154699610 | |
| 0.103 | 0.324 | 0.45 | Alpha-glucosidase inhibitor | 0.45 0.096 CID_154699610 | CID_154699610 | |
| 0.034 | 0.26 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 CID_154699610 | CID_154699610 | |
| 0.016 | 0.247 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.08 0.02 CID_154699610 | CID_154699610 | |
| 0.097 | 0.332 | 0.192 | DNA synthesis inhibitor | 0.192 0.135 CID_154699610 | CID_154699610 | |
| 0.034 | 0.276 | 0.054 | Lipocortins synthesis agonist | 0.054 0.052 CID_154699610 | CID_154699610 | |
| 0.116 | 0.368 | 0.337 | Apoptosis antagonist | 0.337 0.062 CID_154699610 | CID_154699610 | |
| 0.045 | 0.321 | 0.12 | Estrogen antagonist | 0.12 0.056 CID_9904747 | CID_9904747 | |
| 0.059 | 0.337 | 0.266 | Platelet adhesion inhibitor | 0.266 0.044 CID_154699610 | CID_154699610 | |
| 0.106 | 0.385 | 0.301 | Peptidyltransferase inhibitor | 0.301 0.024 CID_154699610 | CID_154699610 | |
| 0.061 | 0.341 | 0.283 | Hepatoprotectant | 0.283 0.035 CID_154699610 | CID_154699610 | |
| 0.046 | 0.347 | 0.13 | MAP3K9 inhibitor | 0.13 0.095 CID_154585067 | CID_154585067 | |
| 0.051 | 0.358 | 0.254 | Nitric oxide antagonist | 0.254 0.051 CID_154699610 | CID_154699610 | |
| 0.088 | 0.398 | 0.326 | Immunomodulator | 0.326 0.069 CID_154699610 | CID_154699610 | |
| 0.034 | 0.347 | 0.201 | Lipid peroxidase inhibitor | 0.201 0.041 CID_154699610 | CID_154699610 | |
| 0.032 | 0.346 | 0.167 | Thrombolytic | 0.167 0.069 CID_154699610 | CID_154699610 | |
| 0.038 | 0.365 | 0.124 | Anticoagulant | 0.124 0.107 CID_154699610 | CID_154699610 | |
| 0.027 | 0.387 | 0.1 | Estrogen receptor beta antagonist | 0.1 0.064 CID_9904747 | CID_9904747 | |
| 0.034 | 0.404 | 0.417 | Angiogenesis stimulant | 0.417 0.019 CID_154699610 | CID_154699610 | |
| 0.047 | 0.43 | 0.391 | Antioxidant | 0.391 0.036 CID_154699610 | CID_154699610 | |
| 0.039 | 0.433 | 0.346 | Free radical scavenger | 0.346 0.04 CID_154699610 | CID_154699610 | |
| 0.005 | 0.4 | 0.091 | Antineoplastic antibiotic | 0.091 0.05 CID_154699610 | CID_154699610 | |
| 0.062 | 0.507 | 0.541 | Antibacterial | 0.541 0.03 CID_154699610 | CID_154699610 | |
| 0.005 | 0.517 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 CID_154699610 | CID_154699610 | |
| 0.01 | 0.596 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 CID_154699610 | CID_154699610 | |
| 0.046 | 0.66 | 0.454 | Apoptosis agonist | 0.454 0.09 CID_154699610 | CID_154699610 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |